Early detection and curative treatment of hepatocellular carcinoma: A cost‐effectiveness analysis in France and in the United States

Hepatocellular carcinoma (HCC) is the leading cause of death in patients with cirrhosis. Patients outside clinical trials seldom benefit from evidence‐based monitoring. The objective of this study was to estimate the cost‐effectiveness of complying with HCC screening guidelines. The economic evaluat...

Full description

Saved in:
Bibliographic Details
Published in:Hepatology (Baltimore, Md.) Vol. 65; no. 4; pp. 1237 - 1248
Main Authors: Cadier, Benjamin, Bulsei, Julie, Nahon, Pierre, Seror, Olivier, Laurent, Alexis, Rosa, Isabelle, Layese, Richard, Costentin, Charlotte, Cagnot, Carole, Durand‐Zaleski, Isabelle, Chevreul, Karine
Format: Journal Article
Language:English
Published: United States Wolters Kluwer Health, Inc 01.04.2017
Subjects:
ISSN:0270-9139, 1527-3350, 1527-3350
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Be the first to leave a comment!
You must be logged in first